Drug Discovery

Recursion Stock – Revolutionizing Drug Discovery With AI

Technological advancement makes people uncomfortable, and artificial intelligence (AI) is no exception. It’s going to uncover things we don’t like, things we cannot explain, and things that truly impact mankind – maybe even all at the same time. How it can possibly add so much value may remain a mystery at times. For us to […]

Company Uses AI Drug Discovery for Designing Biologics

The bright minds at Insilico Medicine announced just today a major breakthrough in the rapidly growing field of AI drug discovery. The Hong Kong startup used a type of AI system called deep learning to simultaneously identify both a small-molecule drug and its ideal biological target to treat pulmonary fibrosis. It took just 18 months […]

The Leader in Artificial Intelligence For Drug Discovery

When you’re a young male, you spend your money on cheap booze, hard drugs, and fast women – and the rest you waste. As you enter old age, you increase your spending on drugs, the type needed to treat the chronic problems you developed from abusing your body so much during your youth. The end […]

What Happened to 3D-Printed Drugs?

Healthcare is usually seen as pretty recession proof. After all, when things head south, our health can go sideways. But the current pandemic has reportedly wiped out 1.4 million jobs in the medical field. (Do you really want to go in for that nose job and leave with a potentially deadly pulmonary infection?) While the […]

The Lantern Pharma IPO Raises Some Questions

We recently published a report on seven AI healthcare stocks noting that six were the result of recent IPOs. Of those, two are involved in drug discovery. We’ve written extensively about how machine learning and computational chemistry are speeding up the drug development process and decreasing the likelihood that drugs will fail. It’s all about […]

A Computational Chemistry IPO From Schrodinger

Elon Musk once said that there’s a one in a billion chance we’re not living in a simulation. Sounds far-fetched until you start digging into simulation theory a bit. It’s backed by theories from leading academics, like Nick Bostrom’s “simulation argument,” which presents three likelihoods, each equally frightening to ponder. To paraphrase Arthur C. Clarke, it is […]

Insilico Medicine Becomes the Face of AI Drug Discovery

In many industries, there’s usually one or two companies that become nearly synonymous with their particular market. One of the most obvious examples is Coca Cola (KO). Think about it: We still refer to a soda as a coke, even though the soft drink manufacturer allegedly abandoned using cocaine in its formulation long ago. In […]

Simulating Cancer Cells Using Artificial Intelligence

Hoteliers in Hungary must be loving life right about now. In 2018, Hungary set a record of 31 million hotel nights booked by tourists. From obnoxious British stag do goers to snap-happy Chinese mainlanders, the streets of Budapest – that’s Hungary’s capital city for the geographically challenged – are chock full of people enjoying the “Paris of the […]

Virtual Reality for Drug Discovery is for Real

In 2016, the unthinkable happened. Pundits had been predicting a major shakeup was coming that would change the future. Yes, that’s right: The new wave of commercial virtual reality headsets finally hit the market, led by Oculus VR. And then not much changed after the peak year of 2016 when venture capitalists pumped $857 million […]

Universal Flu Vaccine: Can Biotech Companies Deliver?

We love animals here at Nanalyze. We once considered doling out a few hundred dollars for the 30-second opportunity to hold a panda in China, but then figured the money would be better spent on visiting cannabis clubs in Europe. But you know what animal we won’t touch? A squirrel. Why? Those little buggers carry […]